Pharmafile Logo
Pharmafocus logo
Advanced Search

PCTs told to explain how drug funding decisions are reached

September 17, 2008
NHS, hc

The Department of Health has written to PCT chief executives requesting information on how they reach funding decisions on new …

News
Paolo

GSK unveils new cancer unit

September 17, 2008
Research and Development Cancer, GSK

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …

News

Amgen sells off two biotech products

September 16, 2008
Research and Development biotech

Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …

News

Latest news from Datamonitor

September 15, 2008
Sales and Marketing NICE, rcc

UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …

News

Lilly launches diabetes patient education programme

September 12, 2008
Medical Communications, Sales and Marketing diabetes, patients

Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …

News

Patient wins legal battle for Revlimid

September 12, 2008
Sales and Marketing Cancer, Revlimid

A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …

News

Sanofi look for stronger leadership in GSK’s Viehbacher

September 12, 2008
Sales and Marketing Sanofi, restructure

News

The potential and the perils of online recruitment

September 11, 2008
Business Services careers, digi, recruitment

It's easy to be someone different on the internet – a recent conference on Second Life was attended by a …

Feature

Merck Serono takes lead role in antibody partnership

September 11, 2008
Research and Development Merck Serono

Merck Serono has agreed to take on full responsibility for developing a promising antibody from its partner ZymoGenetics. The German …

News

Postcode lottery of care persists in England

September 11, 2008
Sales and Marketing par

A new report identifies widespread variations in how much the NHS spends locally on different diseases. The King's Fund says …

News

Oxford BioMedica unsettled by chief executive’s departure

September 10, 2008
Sales and Marketing Oxford BioMedica, biotech

Confidence has been shaken in Oxford BioMedica following news that its chief executive has stepped down just one month after …

News

Viehbacher leaves GSK for Sanofi

September 10, 2008
Sales and Marketing GSK, Sanofi

Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …

News

Government looks set to allow top-up fees

September 10, 2008
Sales and Marketing Cancer, Karol Sikora, NICE

 Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …

News

Tapping into the audience’s imagination

September 9, 2008
Medical Communications Best of Health, IPA, advertising, awards, event

Feature

Latest news from Datamonitor

September 9, 2008
Sales and Marketing lifecycle

Drug lifecycle management could be the answer to the $100 billion questionGenerics are finding their way onto the drugs market …

News

European research centres unite to battle cancer

September 9, 2008
Research and Development Cancer, EU, France, Netherlands, Sweden

Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …

News

Setback for Pfizer and BMS clotting drug

September 5, 2008
Sales and Marketing BMS, Pfizer, clot, cv

News

Danish court overturns Lipitor patent challenge

September 5, 2008
Sales and Marketing Denmark, Lipitor, Pfizer, generics

A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …

News

Pfizer to co-market new Alzheimer’s drug

September 5, 2008
Sales and Marketing Alzheimer's, Pfizer

 Pfizer is to partner with American firm Medivation to develop and market a new drug for Alzheimer’s and Huntington’s disease.The …

News

Experts play down Inergy cancer risk

September 5, 2008
Sales and Marketing Merck, cv

Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026